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Abstract
Objectives: Diabetic foot ulcer (DFU) is a common complication of diabetes and not only an important factor of
mortality among patients with diabetes but also decreases the quality of life. The short form of Diabetic Foot Ulcer
Scale (DFS-SF) provides comprehensive measurement of the impact of diabetic foot ulcers on patients’ health
related quality of life (HRQoL). The purpose of this study was to translate DFS-SF into Polish and evaluate its
psychometric performance in patients with diabetic foot ulcers.
Methods: The DFS-SF translation process was performed in line with Principles of Good Practice for the Translation
and Cultural Adaptation Process for patient reported outcome measures (PROMs) developed by ISPOR TCA group.
Assessment of the reliability and validity of Polish DFS-SF was performed in native Polish patients with current DFU.
Results: The DFS-SF validation study involved 212 patients diagnosed with DFU, with 4.4 years of DFU duration on
average. The average ulcer size was 5.5 sq. cm, and generally only one limb was affected. Men (72%) and type 2
diabetes patients (86%) prevailed, with 17.8 years representing the mean time since diagnosis. The mean population
age was 62.5 years. The internal consistency of all scales of the Polish DFS-SF was high (Cronbach’s alpha ranged from
0.82 to 0.93). Item convergent and discriminant validity was satisfactory (median corrected item-scale correlation
ranged from 0.61 to 0.81). The Polish DFS-SF demonstrated good construct validity when correlated with the SF-36v2
and showed better psychometric performance than SF-36v2.
Conclusions: The newly translated Polish DFS-SF may be used to assess the impact of DFU on HRQoL in Polish
patients.
Introduction
Diabetic foot ulcer (DFU) is a common complication of
diabetes — it is estimated up to 15–25% of all patients
with diabetes will experience ulceration of the foot dur-
ing their lifetime [1, 2]. Recent studies have showed easy
accessible assessment of the progression of diabetic ret-
inopathy by ophthalmological examination [3]. It is a re-
liable indicator of the perfusion defects in the lower
limbs. However diabetic foot syndrome is still diagnosed
late and ulceration of foot is the main cause of lower ex-
tremity of amputation in diabetes and a major determin-
ant of disability [4]. Diabetic foot syndrome is not only
an important factor of mortality among patients with
diabetes but also decreases quality of life (QoL) [5, 6].
Indeed several trials showed that patents with foot ulcer-
ation have significantly decreased health related quality
of life (HRQoL) compared to those without this compli-
cation. Valensi et al. found that HRQoL measured with
SF-36 was significantly lower for all domains in a group
of patients with foot ulcers compared to those without
foot ulcers [7]. Ribu et al. found that the patients with
diabetic foot ulcer reported significantly poorer HRQoL
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than the diabetes population in all the SF-36 subscales
and in the both SF-36 summary scales [8]. In another
study, Ribu et al. found that after 12 months of observa-
tion, subjects with ulcers that did not heal had HRQoL
significantly lower than that of subjects with healing ul-
cers in five of eight subscales in the SF-36 [9]. Moreover,
Winkley et al. found that the quality of life deteriorates
if foot ulcer recurs or does not heal [10]. Most of cited
studies used SF-36 for quality of life measures and al-
though SF-36 has shown sensitivity when correlating
HRQoL scores with diabetic foot ulcers severity some
study question its sensitivity to ulcer healing [11, 12].
It is suggested that SF-36 measures of HRQoL may
be confounded by non-foot complications of diabetes
[8, 11]. In order to overcome those potential con-
founding factors, a variety of condition— and region-
specific Patient-Reported Outcome Measures (PROMs)
were used to assess HRQoL in patients with diabetic foot
ulcer [13]. The Diabetic Foot Ulcer Scale (DFS) and short
form of the DFS (DFS-SF) provides comprehensive meas-
urement of the impact of diabetic foot ulcers on patients’
QoL [14, 15]. The Diabetic Foot Ulcer Scale consists of 58
items (each on a 5-point Likert-type scale) grouped into
11 domains used to compute 15 QoL subscales: leisure,
physical health, medicine effect, daily life, dependence,
emotions, healthy behaviors, medical compliance, family
life, friends, ulcer care, satisfaction, personal care, positive
relationship and the financial burden [14]. The shorter
form of the DFS, the DFS-SF contains a total of 29 items
(each on a 5-point Likert-type scale) comprising six sub-
scales: leisure, physical health, dependence/daily life, nega-
tive emotions, worried about ulcers/feet and bothered by
ulcer care [15]. This short form of the DFS was developed
to reduce patient burden and proved to have good psycho-
metric properties DFS-SF (original language English) has
been translated to several languages including Chinese,
Dutch, French, Mandarin and Spanish [16]. However, only
the Chinese translation has undergone a full linguistic val-
idation process [17].
To the best of our knowledge, the HRQoL in the
population of patients with DFU in Poland has not been
previously analyzed. Moreover, translated condition—
and region-specific PROMs that assess HRQoL in pa-
tients with diabetic foot ulcer are not currently available
in Poland. The aim of our study was to translate DFS-SF
into Polish and evaluate its psychometric performance.
Secondary objectives of this study were to investigate
the influence of severity of foot ulceration on HRQoL.
Methods
The DFS-SF translation process was performed in line
with Principles of Good Practice for the Translation
and Cultural Adaptation Process for Patient-Reported
Outcomes Measures developed by ISPOR Translation
and Cultural Adaptation group (TCA group) [18]. In
details the translation process included following steps:
preparation; forward translation; reconciliation; back
translation; back translation review; harmonization; cogni-
tive debriefing; review of cognitive debriefing results and
finalization; proofreading; and final report. Permission to
translate the DFS-SF into Polish was obtained in advance
from the Mapi Research Trust (Lyon, France). Assessment
of the reliability and validity of Polish DFS-SF was per-
formed in native Polish patients with current DFU. Pa-
tients were recruited from a survey in the population of
diabetic patients with active foot ulcers who were treated
in ambulatory settings at the Department of Gastroenter-
ology and Metabolic Diseases of the Medical University of
Warsaw. As described in detail previously in our study on
indirect costs associated with DFS in Poland (the partici-
pants overlap between the two studies) data on patients’
clinical condition, i.e., the duration of ulceration, diabetes
type, the duration of diabetes and the duration of current
treatment as well as basic demographic data, including
age, gender, education, place of residence and employment
sector were collected [19]. All questionnaires were self-
administered and oral informed consent have been ob-
tained from the participants (completed questionnaires
documents participant consent). All data were collected
and analyzed anonymously. Study was design as a non-
interventional survey and Medical University of Warsaw
ethics committee based on article 37al Pharmaceutical
Law of 6 September (JL No, 126, item 1381) consolidated
text of 27 February 2008 (JL No. 45, item 271) granted an
exemption from requiring ethics approval [20, 21]. The
severity of ulcers was evaluated using the PEDIS scale
(Perfusion, Extent, Depth, Infection and Sensation classifi-
cation system and score in patients with diabetic foot
ulcer) designed by the International Working Group on
the Diabetic Foot (IWGDF) [22]. The SF-36v2 scale was
used to validate the DFS-SF measures, since SF-36 is con-
sidered a gold standard for measuring QoL including dia-
betes and its complication and has been previously used
for DSF-SF validation [15, 17]. Permission to use Polish
SF-36v2 and scoring software (QualityMetric Health
Outcomes™ Scoring Software 4.5.1) was obtained from the
QualityMetric Inc. (Lincoln, RI, USA).
The DFS-SF subscales scores were computed based
on scoring conventions published elsewhere [15]. In
details, the raw item scores were reverse coded so
that the minimum possible score represented the
worst quality of life, and the maximum possible score
represented the best quality of life. Therefore, items
were aggregated within each six subscales and then
transformed to a score from 0 to 100, with higher
scores indicating better quality of life for each sub-
scale. Subscale Scores were calculated when less than
50% of the items for that subscale were missing. The
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missing responses were replaced by the mean of the
item responses in the scale.
Acceptability (quality of data) of Polish DFS-SF were
assessed by completeness of data and score distributions.
We assumed that quality of data will be acceptable based
on following criteria: i) missing data for summary scores
<5%, ii) even distribution of endorsement frequencies
across response categories and iii) floor/ceiling effects
for summary scores <10% [23].
Item convergent validity was assessed by calculating
the corrected item-scale correlations, i.e. the Spearman
rank correlation between an item and the score of its hy-
pothesized scale after removing the item. For each sub-
scale, the item convergent validity was computed as the
percentage of its items with corrected item-scale correl-
ation of at least 0.6, consistent with a strong correlation
in social science [24]. The item discriminant validity was
computed as the percentage of items whose corrected
item-scale correlation was greater than the correlation
with other subscales of DFS-SF. Internal consistency of
each subscale was examined using the Cronbach’s alpha
coefficient. A Cronbach’s alpha coefficient value of
greater than 0.70 was considered acceptable for the use
of multi-item scales in conducting comparisons between
groups [25].
Criterion validity was examined by Spearman’s rank
correlation coefficient between DFS-SF and SF-36v2.
Differential item functioning (DIF), i.e. excess correlation
of a background characteristic with an item, beyond the
association of the item with the score, was tested with
ordinal logistic regression. We tested if background
characteristics (sex, age, place of residence, education,
type of diabetes, time from diagnosis of diabetes), when
added to the baseline model explaining the item by
the score, were significant as explanatory variables
(calculations done in R, using chi-square statistic).
Correlations between severity of foot ulceration mea-
sured with the PEDIS scale or ulcer diameter and HRQoL
were examined by Spearman’s rank correlation coefficient
(rho). Hypothesis testing for differences between HRQoL
in groups with different severity of foot ulceration was
conducted using non-parametric tests, including the
Mann Whitney-U test (to compare two groups) or the
Kruskal-Wallis test (to compare more than two groups).
The significance level in null hypothesis testing was set to
5% (α = 0.05). Statistical calculations were conducted using
StatSoft, Inc. (2011) STATISTICA (data analysis software
system), version 10. Tulsa, Oklahoma, USA, R version
3.3.2 Copyright (C) 2016 The R Foundation for Statistical
Computing and Microsoft Office Excel 2010.
Results
During the translation process, we did not modify
any items but one major modification to DFS-SF
questionnaire was made in order to improve the read-
ability of the DFS-SF in Poland. Since some items in
Polish have more elaborated descriptions, and because
of the blurred vision in most DFU patients, we de-
cided to use landscape (horizontal) instead of portrait
(vertical) orientation of questionnaire. This allowed us to
maintain enlarged fonts and made the questionnaire more
readable (see Additional file 1: Appendix 1).
The DFS-SF validation study involved 212 patients di-
agnosed with DFU, with 4.4 years of DFU duration on
average. Men (72%), residents of urban areas (79%) and
type 2 diabetes patients (86%) prevailed, with 17.8 years
representing the mean time since diagnosis. The mean
population age was 62.5 years. More than 50% of pa-
tients had no perfusion abnormalities in the affected
limb, and approximately 40% had a superficial full-
thickness ulcer, generally without clinical symptoms of
generalized infection. In the vast majority of patients
(89%), loss of protective sensation was present. The aver-
age ulcer size was 5.5 sq. cm, and generally only one
limb was affected. Detailed demographic and clinical
characteristics of the patient population are presented in
Table 1.
Quality of data were acceptable — missing data for
summary scores were <5% for almost all items (see
Additional file 2: Appendix 3). DFS-SF is a 5-point
Likert-type scale with minimum possible score (1) repre-
sented the best quality of life and the maximum possible
score (5) represented the worst quality of life. Given the
nature of question items we can divide 5-point Likert-
type scale to two positive, two negative and one neutral
responses. The distribution of between positive (scores 1
and 2) and negative (scores 4 and 5) categories for all 29
items combined indicate no balance between positive
(25.3%) and negative (52.8%) responses (see Additional
file 2: Appendix 3). Uniform distribution would provide
a mean percentage frequency of 20% for each of the 5
categories. As presented in figure in Additional file 2:
Appendix 3, percentage frequency of positive re-
sponses (scores 1 and 2) were well below this value.
In contrast, relatively high percentage frequency re-
sponses for score 4 was observed. The results of the
Chi square tests indicate that the frequency distribu-
tion of responses amongst the 5 categories was not
uniform. Indeed when comparing floor/ceiling effects
for summary scores a relatively high floor percentage
was found in the ‘leisure’ subscale (16.2%). None of
the other subscales reached 10% of their floor per-
centage. However, the ceiling percentage was also low
in all subscales of the Polish DFS-SF. It should be no-
tated that in three subscales: ‘worried about ulcers/
feet’, ‘negative emotions’ and ‘bothered by ulcer care’
none of the patients scored at the maximum level. A
summary of result is provided in Table 2.
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The internal consistency of all subscales of the Polish
DFS-SF was high (Cronbach’s alpha ranged from 0.83 to
0.94) and comparable to those in English DFS-SF — see
Table 2.
Item convergent validity was satisfactory — all but one
(item 4I in the ‘negative emotions’ subscale) corrected
item-scale correlations were >0.6 and median corrected
item-scale correlation ranged from 0.61 to 0.81 — see
Table 3 and Additional file 3: Appendix 2. Also item dis-
criminant validity was satisfactory — the vast majority of
items corrected correlations with the scale were greater
than the correlations with other scales — see Table 3
and Additional file 3: Appendix 2. However there were
some exception e.g. — item 4I in the ‘worried about
ulcers/feet’ subscale had a corrected item-scale correl-
ation of 0.63 but had a correlation of 0.73 with the
‘negative emotions’ subscale. This was expected since
this item is shared in both those subscale and item 4I in
the ‘negative emotions’ subscale had a corrected item-
scale correlation of 0.54 but had a correlation of 0.75
with the ‘worried about ulcers/feet’ subscale. The
‘bothered by ulcer care’ subscale had the lowest item dis-
criminant validity. Item - 5D in this subscale had a cor-
rected item-scale correlation of 0.61 but had a correlation
of 0.67 with the ‘dependence/daily life’ subscale.
No DIF was found in most DFS-SF items. In only
three cases did the demographic characteristics impact
the item in a statistically significant way (see Additional
file 4: Appendix 4): place of residence for item 2E (‘pain
during night’), sex for item 3C (‘depend on others to get
out of the house’), and both age and time from diagnosis
of diabetes for item 5C (‘bothered by appearance of
ulcer’). Because in total we had 29 items and 6 back-
ground characteristics tested (and so multiply hypoth-
eses), we conclude there is no problem with DIF, i.e.
with members of various subgroups interpreting items
differently.
There were moderate associations among the Polish
DFS-SF subscales, with a high positive correlation (0.82)
between ‘worried about ulcers/feet’ and ‘negative
emotions’ — see Table 4. This is not a surprise since
Table 1 Demographic and clinical characteristics of patients
Male, [n (%)] N = 212 153 (72.2%)
Age [mean (SD)] N = 210 62.5 (10.4)







Urban area of more
than 500 thousand.
98 (46.4%)
Education [n (%)] N = 212 Primary 36 (17.0%)
Secondary 138 (65.1%)
Higher 38 (17.9%)
Type of diabetes [n (%)] N = 211 Type 1 27 (12.8%)
Type 2 181 (85.8%)
Other 3 (1.4%)
Time (years) from diagnosis of diabetes [mean (SD)] N = 209 17.8 (11.6)
Time (years) from diagnosis of DFU [mean (SD)] N = 210 4.4 (4.7)
Time (weeks) of actual ulcer treatment [mean (SD)] N = 212 52.1 (99.0)
Size of ulcers in sq. cm [mean (SD)] N = 203 5.5 (10.3)
Perfusion [n (%)] N = 207 Grade 1 110 (53.1%)
Grade 2 85 (41.1%)
Grade 3 12 (5.8%)
Depth/tissue loss [n (%)] N = 210 Grade 1 84 (40.0%)
Grade 2 81 (38.6%)
Grade 3 45 (21.4%)
Infection [n (%)] N = 210 Grade 1 97 (46.2%)
Grade 2 64 (30.5%)
Grade 3 46 (21.9%)
Grade 4 3 (1.4%)
Sensation [n (%)] N = 210 Grade 1 23 (11.0%)
Grade 2 187 (89.0%)
Number of limbs affected [n (%)] N= 191 One 184 (96.3%)
Both 7 (3.7%)
Table 2 Polish Diabetic Foot Ulcer Scale - Short Form results in patients with active diabetic foot ulcer
Subscale of DFS-SF Mean Median SD Floor % Ceiling % Cronbach’s alpha
Polish English
Leisure 35.4 25.0 29.3 16.2% 2.5% 0.93 0.90
Physical health 43.5 45.0 22.6 5.4% 0.5% 0.87 0.86
Worried about ulcers/feet 41.7 41.7 23.8 3.4% 0.0% 0.92 0.84
Dependence/daily life 47.7 50.0 29.3 7.8% 2.9% 0.90 0.88
Negative emotions 34.8 30.0 23.3 9.8% 0.0% 0.89 0.93
Bothered by ulcer care 38.1 37.5 24.1 6.6% 0.0% 0.82 0.80
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those subscales share common item (4I) and both are re-
lated to patients’ emotions.
The Polish DFS-SF demonstrated good construct val-
idity when correlated with the SF-36v2 — see Table 5.
Although we did not identify DFS-SF subscales related
to physical components (‘leisure’, ‘physical health’,
‘dependence/daily life’) to have significantly better cor-
relation with physical component subscales of the SF-
36v2 (i.e. ‘physical functioning’, ‘role physical’, and ‘bodily
pain’) rather than mental component subscales of the
SF-36v2 (i.e. ‘mental health’, ‘role emotional’, and ‘social
functioning’), but similar regularities as for original
(English) DFS-SF were observed i.e. strong correlation of
DFS-SF ‘physical health’ and SF-36v2 ‘vitality’ (rho = 0.56)
and ‘Bodily pain’ (rho = 0.63) [15]. Also, similar to original
DFS-SF, Polish DFS-SF ‘dependence/daily’ was most
highly related to the SF-36v2 ‘physical functioning’
(rho = 0.60) and ‘social functioning’ (rho = 0.58) sub-
scales. Overall, Polish DFS-SF subscales showed stron-
ger correlation with SF-36v2 subscales compared to
the original DFS-SF, especially in ‘worried about ulcers/
feet’ and ‘bothered by ulcer care’ subscales [15].
Weak but significant negative correlations were found
between ulcer size and’bothered by ulcer care’ subscale
of DFS-SF. Surprisingly significant correlations were not
found between ulcer size and other DFS-SF subscales —
see Table 6. Similarly none of correlations were signifi-
cant for the comparison of ulcer size and SF-36v2
subscales — see Table 6. Weak or moderately significant
(except for ‘bothered by ulcer care’) negative correlations
were found between loss of perfusion loss and DFS-SF
subscales. No correlations were found for comparing
both ‘depth/tissue loss’ and ‘infection’ and DFS-SF sub-
scales. Similar regularities but less pronounced were ob-
served for correlations of severity of foot ulceration
(PEDIS scale) and HRQoL measured with SF-36v2, how-
ever surprisingly weak but significant positive correlation
was observed between ‘depth/tissue loss’ and ‘general
health’ subscale of SF-36v2 — see Table 6. Patents with
loss of sensation scored significantly higher in all DFS-
SF and SF-36v2 subscales — see Table 6. However, this
is not a surprise, given that the loss of sensation usually
results with pain reduction.
Discussion
To our knowledge translated condition— and region-
specific PROMs that assess HRQoL in patients with dia-
betic foot ulcer have not been available up to now in
Poland and no comprehensive analysis of HRQoL in the
population of patients with DFU in Poland has been pre-
viously analyzed. The Polish translation of DFS-SF is the
second after the Chinese translation that has undergone
a full linguistic validation process. The present study is
the first to assess of HRQoL in Polish patients with DFU
using condition— and region-specific PROMs - DFS-SF.
The Polish DFS-SF demonstrated good scaling proper-
ties and good validity. The median corrected item-scale
correlations and the internal consistency was excellent
and similar to that of the original English version [15].
Correlations with the SF-36 scales also supported the
Table 3 Item convergent and discriminant validity of the Polish Diabetic Foot Ulcer Scale - Short Form






Leisure 5 100% 100% 0.81 (0.80 – 0.84)
Physical health 5 100% 100% 0.70 (0.64 – 0.74)
Worried about ulcers/feet 6 100% 83% 0.77 (0.63 – 0.81)
Dependence/daily life 5 100% 100% 0.81 (0.66 – 0.83)
Negative emotions 5 80% 80% 0.77 (0.54 – 0.79)
Bothered by ulcer care 4 100% 75% 0.61 (0.61 – 0.68)
a Percentage of items in a scale whose corrected correlation with the scale was >0.6
b Percentage of items in a scale whose corrected correlation with the scale was greater than the correlation with other scales
Table 4 Scale-scale correlations, according to the Spearman rank correlation coefficient — DFS-SF vs DFS-SF
Leisure Physical health Worried about ulcers/feet Dependence/daily life Negative emotions Bothered by ulcer care
Leisure 1.00 0.51 0.64 0.69 0.48 0.56
Physical health 1.00 0.64 0.66 0.54 0.56
Worried about ulcers/feet 1.00 0.64 0.82 0.72
Dependence/daily life 1.00 0.50 0.64
Negative emotions 1.00 0.63
Bothered by ulcer care 1.00
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construct validity of the Polish DFS-SF but also showed
that Polish patients worries about ulcer care and both-
ered by treatment are more pronounced than in the
English or Chinese population [15, 17]. This comes well
with Polish experts opinions which concluded that out-
patient care of patients with DFU is underfunded, diffi-
cult to access and the condition of treatment is unsatis-
factory (source: experts’ on DFU survey). It is worth
noting that our survey on direct cost of treatment
among patients with DFU showed that more than 2/3 of
out-patients specialist consultations are conducted in
private care causing significant financial burden for
patients.
The Polish DFS-SF also demonstrated good psycho-
metric performance. Study on the influence of severity
of foot ulceration on HRQoL showed DFS-SF is a more
sensitive instrument than SF-36v2 when correlated with
severity of ulceration measured with the PEDIS scale.
Although it is worth noticing very modest correlation of
ulcers’ severity and HRQoL was identified. Better sensi-
tivity of DFS-SF is expected since SF-36v2 is a generic
questionnaire and it was previously suggested that SF-36
measures of HRQoL may be confounded by non-foot
complications of diabetes [9, 12]. However it is worth
mentioning that SF-36v2 not DFS-SF can be easily con-
verted to utility score for the purpose of economic
evaluation.
We also verified DIF presence, in a simple logistic re-
gression approach. Reassuringly, only 3 out of 29 items
(and out of 6 background variables tested) have signifi-
cant DIF. However, due to small sample sizes and the
fact that our study was not originally planned to test
Table 5 Scale-scale correlations, according to the Spearman rank correlation coefficient — DFS-SF vs SF-36v2
Leisure Physical health Worried about ulcers/feet Dependence/daily life Negative emotions Bothered by ulcer care
Physical functioning 0.57 0.47 0.43 0.60 0.27 0.46
Role physical 0.59 0.38 0.46 0.54 0.34 0.46
Bodily pain 0.52 0.63 0.52 0.46 0.43 0.52
General health 0.41 0.46 0.52 0.39 0.50 0.43
Vitality 0.45 0.56 0.50 0.42 0.37 0.45
Social functioning 0.56 0.53 0.57 0.58 0.41 0.54
Role emotional 0.55 0.41 0.54 0.49 0.41 0.42
Mental health 0.46 0.55 0.60 0.41 0.48 0.48
Table 6 Spearman rank correlation coefficient (except for ‘sensation’) between severity of foot ulceration (PEDIS scale) and HRQoL
measured with DFS-SF and SF-36v2
Ulcer size Perfusion Depth/tissue loss Infection Sensationa
DFS-SF
Leisure −0,066 −0.253* −0.079 −0.011 0.001
Physical health 0,016 −0.287* 0.019 −0.005 <0.001
Worried about ulcers/feet −0,003 −0.184* −0.031 −0.019 0.001
Dependence/daily life −0,094 −0.312* −0.009 −0.009 <0.001
Negative emotions −0,081 −0.225* −0.055 −0.063 <0.001
Bothered by ulcer care −0,154* −0.126 −0.057 −0.109 0.002
SF-36v2
Physical functioning −0,045 −0.259* −0.153* −0.089 0.000
Role physical −0,132 −0.131 −0.097 −0.103 0.044
Bodily pain −0,041 −0.193* −0.069 −0.082 0.000
General health 0,138 −0.112 0.189* 0.135 0.003
Vitality 0,038 −0.232* 0.029 0.036 0.003
Social functioning −0,052 −0.104 −0.008 −0.039 0.002
Role emotional 0,000 −0.189* −0.005 0.013 0.007
Mental health 0,053 −0.143* −0.002 −0.024 0.001
* p < 0.05
a Mann Whitney-U test
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DIF, these findings require further development. To the
best of our knowledge, DIF have not been previously an-
alyzed in DFS-SF.
At last, it should be noted that we’ve observed signifi-
cant unbalance between positive and negative responses
that might suggest trend for scoring lower in Polish
DFS-SF. Indeed, when compare to Chinese DFS-SF,
Polish patients scored significantly lower in all six sub-
scales [17]. These differences may be due to differences
in patient characteristics (i.e. some Chinese patients had
healed foot ulcer), but it also may arise from trends
shown in Polish population to score QoL lower compare
to other developed countries. These was observed in
QoL measures with either generic, e.g. EuroQol 5-
Dimensions (EQ-5D) or condition-specific PROMs, e.g.
Multiple Sclerosis Impact Scale (MSIS-29) [26, 27].
Small, but still visible differences in scoring against
Polish population compare to other developed countries
(Spain, Finland), has been observed in QoL measures in
the aging population performed with the World Health
Organization Quality of Life Assessment instrument
(WHOQOL-AGE) [28].
In conclusion, the newly translated Polish DFS-SF may
be used to assess the impact of diabetic foot ulceration
on HRQoL in Polish patients, however data from differ-
ent countries should be compared with caution.
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